Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
Tags:
COPD, biologics, clinical trials, GSK, Nucala, AstraZeneca, Fasenra, Roche, astegolimab, Sanofi, Regeneron, Dupixent
AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines
Yahoo/Benzinga
Thu, 07/25/24 - 11:07 am
Tags:
AstraZeneca, earnings
FDA Flags Potential ‘Overtreatment’ for NSCLC With AstraZeneca’s Imfinzi Ahead of Adcomm
BioSpace
Wed, 07/24/24 - 11:32 am
Tags:
AstraZeneca, Imfinzi, non-small cell lung cancer, FDA
AstraZeneca plants an EGFR tree with Pinetree deal worth $45M
Fierce Biotech
Tue, 07/23/24 - 06:24 pm
Tags:
AstraZeneca, Pinetree Therapeutics, EGFR
J&J, BMS and AstraZeneca strike back in appeals after IRA litigation losses
Fierce Pharma
Tue, 07/16/24 - 12:00 pm
Tags:
Inflation Reduction Act, Medicare, drug pricing, JNJ, Bristol Myers Squibb, AstraZeneca
AstraZeneca appoints WPP as one of its primary oncology network partners
Medical Marketing and Media
Wed, 07/10/24 - 11:15 am
Tags:
AstraZeneca, WPP, oncology, advertising
AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
Clinical Trials Arena
Mon, 07/8/24 - 11:33 am
Tags:
AstraZeneca, Aptamer Group, siRNA
AstraZeneca files rival to Pemgarda for COVID PrEP
Pharmaphorum
Mon, 07/1/24 - 11:08 am
Tags:
AstraZeneca, COVID-19, COVID PrEP, sipavibart
AstraZeneca’s Imfinzi fails adjuvant trial in lung cancer
Pharmaphorum
Tue, 06/25/24 - 11:25 am
Tags:
AstraZeneca, Imfinzi, clinical trials, non-small cell lung cancer
Supreme Court gives pharma giants another chance to sidestep terrorism-funding case
Fierce Pharma
Mon, 06/24/24 - 10:08 pm
Tags:
legal, AstraZeneca, GE Healthcare, JNJ, Pfizer, Roche, terrorism
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
Tags:
FDA, Eli Lilly, donanemab, Alzheimer's disease, Adaptimmune, afami-cel, advanced synovial sarcoma, Lykos Therapeutics, MDMA, PTSD, Bristol Myers Squibb, KarXT, schizophrenia, Daiichi Sankyo, AstraZeneca, Dato-DXd, non-small cell lung cancer
AstraZeneca’s Truqap flops in phase III triple-negative breast cancer trial
BioSpace
Tue, 06/18/24 - 11:46 am
Tags:
AstraZeneca, Truqap, triple-negative breast cancer
AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer
Reuters
Mon, 06/17/24 - 11:31 am
Tags:
AstraZeneca, Imfinzi, endometrial cancer, FDA
AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
Clinical Trials Arena
Mon, 06/17/24 - 11:21 am
Tags:
AstraZeneca, clinical trials, Calquence, MCL, mantle cell lymphoma
ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation
Fierce Pharma
Mon, 06/3/24 - 12:10 pm
Tags:
ASCO 2024, AstraZeneca, Tagrisso, Imfinzi, lung cancer, non-small cell lung cancer
ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer
Fierce Pharma
Sun, 06/2/24 - 02:46 pm
Tags:
ASCO 2024, AstraZeneca, Daiichi Sankyo, Enhertu, breast cancer
AstraZeneca throws its hat into the oral PCSK9 ring
Pharmaphorum
Wed, 05/29/24 - 11:28 am
Tags:
AstraZeneca, PCSK9 inhibitors, cholesterol, AZD0780
FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters
Tue, 05/28/24 - 10:29 pm
Tags:
Amgen, AstraZeneca, biosimilars, Soliris, Bkemv
Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far?
BioSpace
Fri, 05/24/24 - 11:14 am
Tags:
AstraZeneca, R&D
AstraZeneca’s $80B sales goal by 2030 reflects industry’s penchant for long-term bets
Pharma Voice
Thu, 05/23/24 - 10:53 am
Tags:
AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.